top of page

The CEO of BioArctic talks Leqembi and what's next in Alzheimer's, Parkinson's, ALS, and more

  • blonca9
  • Sep 21, 2024
  • 1 min read

Gunilla Osswald talks about the global approvals Leqembi has received, she makes the case for a European approval, and talks about what BioArctic has in R&D, including a "BrainTransporter" technology that helps get antibodies into the brain more efficiently.



ree

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

evaluate-logo-png_seeklogo-457165-2_edited.png

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

bottom of page